Targeted delivery of drugs to the gastrointestinal tract

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 18, Issue 4, 2001, Pages 341-386

  Lavelle, E C ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Bioadhesion; Drug delivery; Gastrointestinal tract; Lectin; Targeting; Vaccine

Indexed keywords

ADHESIVE AGENT; CYANOCOBALAMIN; IMMUNOGLOBULIN A; IMMUNOTOXIN; LECTIN; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE; VACCINE;

BACTERIUM ADHERENCE; DRUG DELIVERY SYSTEM; DRUG TARGETING; EPITHELIUM CELL; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GLYCOCALYX; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; MOUSE; NONHUMAN; PEYER PATCH; RAT; REVIEW; TRANSCYTOSIS;

EID: 0034797445     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v18.i4.10     Document Type: Review

References (276)

1. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs
2. Structure and function of the intestinal epithelial barrier in health and disease
3. Structural specialisations for antigen uptake and processing in the digestive tract
4. Molecular and cellular basis of immune protection of mucosal surfaces
5. Vaccines for mucosal immunity to combat emerging infectious diseases
6. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track
7. Structure and mucosal adjuvanticity of cholera and Escherichia coli enterotoxins
8. Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants
9. Antigen uptake by M cells for effective mucosal vaccines
10. Penetration and enzymatic barriers to peptide absorption
11. M cells and microbial pathogeni
12. Organization chemistry and assembly of the cytoskeletal apparatus of the intestinal brush border
13. The filamentous brush border glycocalyx, a mucin-like marker of enterocyte hyper-polarization
14. Anchoring and biosynthesis of stalked brush border membrane glycoproteins
15. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting
16. Modulation of antigen trafficking to MHC class II-positive late endosomes of enterocytes
17. Microparticles as oral vaccines
18. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen
19. Biodegradable microparticles for oral immunization
20. Antigen delivery systems: New approaches to mucosal immunization
21. The common mucosal immune system and current strategies for induction of immune responses in external secretions
22. M cells as portals of infection: Clinical and pathophysiological aspects
23. Mucosal immunity and tolerance: Relevance to vaccine development
24. Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis
25. Migration of lymphocytes in the mucosal immune system
26. New strategies for using mucosal vaccination to achieve more effective immunization
27. Alternate mucosal immune system: Organised Peyer's patches are not required for IgA responses in the gastrointestinal tract
28. Secretory immunoglobulin A: From mucosal protection to vaccine development
29. Mucosal immunity and inflammation. I. Mucosal dendritic cells: Their specialized role in initiating T cell responses
30. Antigen-presenting function of the macrophage
31. Antigen-presenting cells and mechanisms of antigen presentation
32. Antigen presenting T cells. II. Clinical responses to alloreactive and virus-specific self-restricted human cytotoxic T cell responses stimulated by T lymphoblasts
33. Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation
34. Evidence for function of Ia molecules on gut epithelial cells in man
35. Cathepsin E in follicle associated epithelium of intestine and tonsils: Localization to M cells and possible role in antigen processing
36. Induction and regulation of IgA responses in the microenvironment of the gut
37. Dendritic cells the major antigen-presenting cells of the human colonic lamina propria
38. Entry sites for oral vaccines and drugs: A role for M cells enterocytes and dendritic cells?
39. Immune responses to dietary antigens: Oral tolerance
40. Modulating dendritic cells to optimize mucosal immunization protocols
41. Heterogeneity of M cell-associated B and T cells in human Peyer's patches
42. Surface phenotype of Peyer's patch germinal center cells: Implications for the role of germinal centers in B cell differentiation
43. T helper cells for mucosal immune responses
44. Gut mucosal immunization with reovirus serotype I/L stimulates virus-specific cytotoxic T cell precursors as well as IgA memory cells in Peyer's patches
45. Intestinal barriers to bacteria and their toxins
46. Observation on the ultrastructure and function of the so-called "microfold" or "membranous" cells (M cells) by means of peroxidase as a tracer
47. Microparticles and polymers for the mucosal delivery of vaccines
48. Antigen sampling across epithelial barriers and induction of mucosal immune responses
49. Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch
50. Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyer's patch M cells
51. Aminopeptidase activity in the jejunal and ileal Peyer's patches of the albino rabbit
52. Oral protein drug delivery
53. Differential surface characteristics of M cells from mouse intestinal Peyer's and caecal patches
54. The number and distribution of lymphoid follicles in the human large intestine
55. Lymphoglandular complexes of the colon: Structure and distribution
56. Membranous cells as a portal of Mycobacterium pseudotubercolosis entry into rabbit ileum
57. Colonic lymphoid patches: A portal of entry in mice for type 1 reovirus administered anally
58. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes
59. Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses
60. Enterocyte-lymphocyte interactions in the follicle-associated epithelium of the mouse Peyer's patch
61. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue
62. Evidence that membranous (M) cell genesis is immunoregulated
63. M cell: The main entrance of the mucosal immune system
64. Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a
65. Chitosans as absorption enhancers for poorly absorbable drugs. 2. Mechanism of absorption enhancement
66. Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions
67. The potential of receptor-mediated endocytosis for oral drug delivery
68. Poliovirus type 1 enters the human host through intestinal M cells
69. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius appendix and Peyer's patches: An electron microscopic study
70. Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: An ultrastructural study
71. Carbohydrate-mediated liposomal targeting and drug-delivery
72. Molecular studies of the intestinal mucosal barrier physiopathology using cocultures of epithelial and immune cells: A technical update
73. M-cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: A mechanism for antigen sampling and for microbial transepithelial migration
74. M cells and host defense
75. Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants
76. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis
77. Development of the gastrointestinal mucosal barrier. IV. The effect of inhibition of proteolysis on the uptake of macromolecules by the intestine of the newborn rabbit before and after weaning
78. Coating of tablets and small particles with acrylic resins by fluid bed technology
79. Targeting of drugs and vaccines to the gut
80. Immune responses to Streptococcus sobrinus surface protein A expressed by recombinant. Salmonella typhimurium
81. Induction of rotavirus-specific cytotoxic T-lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes
82. ISCOMS: A novel strategy for mucosal immunization
83. Antimicrobial and immunostimulatory effects of orally administered saponins
84. Enhancement of specific and mucosal immune responses following oral administration of liposomes
85. Properties of practical oral liposome: Streptococcus mutans glucosyltransferase caries vaccines for effective induction of protection
86. Recent advances in cellular sub-cellular and molecular targeting
87. Hydrogels for site-specific drug delivery to the colon: In vitro and in vivo degradation
88. Comparison of poly (DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells
89. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches
90. Lectin-mediated mucosal delivery of drugs and microparticles
91. Transit of pharmaceutical dosage forms through the small intestine
92. Mucoadhesive drug delivery systems
93. Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug
94. Adhesive topical drug delivery systems
95. Molecular aspects of muco- and bioadhesion: Tethered structures and site-specific surfaces
96. A hydrophobically modified bioadhesive polymeric carrier for controlled drug delivery to mucosal surfaces
97. Biologically erodible microspheres as potential oral drug delivery systems
98. Polymers with thiol groups: A new generation of mucoadhesive polymers?
99. From sticky stuff to sweet receptors: Achievements limits and novel approaches to bioadhesion
100. Specific and nonspecific bioadhesive particulate systems for oral delivery to the gastrointestinal tract
101. Monoclonal antibody directed targeting of fluorescent microspheres to Peyer's patches M cells
102. Biological effects of plant lectins on the gastrointestinal tract: Metabolic consequences and applications
103. What should be called a lectin?
104. Isolation and chemical properties of lectins
105. Lectins as plant defense proteins
106. Plant lectins: A special class of plant proteins
107. Characterization and molecular cloning of two different type 2 ribosome-inactivating proteins from the monocotyledonous plant
108. Ribosome-inactivating proteins from plants
109. Recent advances in the uses and applications of ribosome-inactivating proteins from plants
110. Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins
111. Lectins in the United states diet: A survey of lectins in commonly consumed foods and a review of the literature
112. Incorporation of the reovirus M-cell attachment protein into small unilamellar vesicles: Incorporation efficacy and binding capacity to L929 cells in vitro
113. A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29
114. Conservation of the D-mannose-adhesion protein among type I fimbriated emebers of the family Enterobacteriaeceae
115. Fimbriae and adhesive properties in dysenteric bacilli
116. Fimbriae and adhesive properties in Salmonellae
117. Adherence of Salmonella typhimurium to small intestinal enterocytes of the rat
118. Role of type 1 and type 3 fimbriae on the adherence and pathogenesis of Salmonella enteriditis in mice
119. Mannose-sensitive haemagglutinins in adherence of Vibrio cholerae El Tor to intestine
120. Electron microscopic study of Vibrio cholerae O1 adherence to the mucus coat and villus surface in the human small intestine
121. Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of Shigellosis
122. Acute inflammation causes epithelial invasion and mucosal destruction in experimental Shigellosis
123. Involvement of M cells in the bacterial invasion of Peyer's patches: A common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria
124. Bacterial entry into eukaryotic cells
125. Role of M cells and macrophages in the entrance of Mycobacterium paratuberculosis into domes of ileal Peyer's patches in calves
126. Functional morphology of microfold cells (M cels) in Peyer's patches Phagocytosis and transport of BCG byM cells into rabbit Peyer's patches
127. Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells
128. Adherence of Salmonella typhimurium to Caco-2 cells: Identification of a glycoconjugate receptor
129. Immunization of mice against various strains of Pseudomonas aeruginosa by using Pseudomonas lectin vaccine
130. Pertussis antigens that abrogate bacterial adherence and elicit immunity
131. Cry1Ac protoxin from Bacillus thuringiensis sp kurstaki HD73 binds to surface proteins in the mouse small intestine
132. Proteolytic processing of reovirus is required for adherence to intestinal M cells
133. Antigenicity immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica
134. A protein secreted by Trypanosoma cruzi capable of inducing the entry of inert particles into HeLa cells
135. Leishmania-host-cell interaction: Complexities and alternative views
136. Trichomonad invasion of the mucous layer requires adhesins mucinases and motility
137. Adherence of nonfimbriated enteroinvasive Escherichia coli O124 to guinea pig intestinal tract in vitro and in vivo
138. Galectin-2, galectins -5 and -9, and galectins -4 and -6
139. Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract
140. Identification and characterisation ofgalectin-9 A novel beta-galactoside-binding mammalian lectin
141. The D-galactosebinding lectin of the octocoral Sinularia lochmodes: Characterization and possible relationship to the symbiotic dinoflaggelates
142. Purification and characterization of a novel lectin from a freshwater cyanobacterium. Oscillatoria agardhii
143. Lectin-like compounds and lectin receptors in marine microalgae: Hemagglutination and reactivity with purified lectins
144. Lectin-mediated drug targeting: Quantification of binding and internalisation of wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells
145. Lectin-mediated bioadhesion: Binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2 HT-29 and HCT-8
146. Lectin-mediated bioadhesion: Proteolytic stability and binding-characteristics of Wheat germ agglutinin and Solanum tuberosum lectin on Caco-2 HT-29 and human colonocytes
147. Lectin-mediated bioadhesion: Preparation stability and caco-2 binding of wheat germ agglutinin-functionalized Poly (DL-lactide-co-glycolic acid)microspheres
148. Lectin-mediated drug targeting: Preparation binding characteristics and antiproliferative activity of wheat germ agglutinin-conjugated doxorubicin on Caco-2 cells
149. The potential of bioadhesive lectins for the delivery of peptide and protein drugs to the gastrointestinal tract
150. Bioadhesion by means of specific binding of tomato lectin
151. Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects
152. Transport of proteins through the membranes of the adult gastro-intestinal tract: A protential for drug delivery?
153. The potential use of tomato lectin for oral drug delivery: 4. Immunological consequences
154. Lectins are sensitive tools for defining the differentiation programs of mouse gut epithelial cell lineages
155. Differential expression of lectin-binding sites defines mouse intestinal M-cells
156. Regional differences in glycoconjugates of intestinal M cells in mice: Potential targets for mucosal vaccines
157. Lectin binding defines and differentiates M-cells in mouse small intestine and caecum
158. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches
159. Selective binding and transcytosis of Ulex europaeus I lectin by mouse Peyer's patch M cells in vivo
160. Variations in lectin binding properties of intestinal M cells
161. Analysis of lectin-binding sites in the gut of hooded Lister rats with special emphasis on recently detected lectins
162. Differential binding of lectins to M cells and enterocytes in the rabbit cecum
163. Epithelial M cells in the rabbit caecal lymphoid patch display distinctive surface characteristics
164. Enterocytes in the FAE of rabbit small intestine display distinctive lectin-binding properties
165. Identification of intact peanut lectin in peripheral venous blood
166. Lectin-binding sites in the epithelium of normal human appendix vermiformis and in acute appendicitis
167. Immunogold localization of ingested kidney bean (Phaseolus vulgaris) lectins in epithelial cells of the rat small intestine
168. Specific uptake of dietary lectins into the systemic circulation of rats
169. The potential use of tomato lectin for oral drug delivery: 3. Bioadhesion in vivo
170. The potential use of tomato lectin for oral drug delivery: 2. Mechanism of uptake in vitro
171. Binding and transport of some bioadhesive plant lectins in the Caco-2 cell model
172. Immunocytochemical localization of ingested kidney bean (Phaseolus vulgaris) lectins in the rat gut
173. Kidney bean (Phaseolus vulgaris) induced lesions in the rat small intestine: Light microscope studies
174. Kidney bean (Phaseolus vulgaris) induced lesions in the rat intestine. 3. Ultrastructural studies
175. Edible mushroom (Agaricus bisporus) lectin which reversibly inhibits epithelial cell proliferation blocks nuclear localization sequence-dependent nuclear protein import
176. Intracellular trafficking and release of intact edible mushroom lectin from HT29 human colon cancer cells
177. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
178. Identification of the site of uptake of the E. coli heat-labile enterotoxin LTB
179. Intestinal tissue distribution and epithelial transport of the oral immunogen LTB the B subunit of E. coli heat-labile enterotoxin
180. Nanocapsules as carriers for oral peptide delivery
181. Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?
182. A method to attach lectins to the surface of spermine alginate microcapsules based on the avidin biotin interaction
183. Lectin-HPMA copolymer conjugates: Potential oral drug carriers for targeting diseased tissues
184. Bioadhesion of lectin-latex conjugates for specific bioadhesion
185. Ulex europaeus I lectin targets to mouse Peyer's patch M-cells in vivo
186. Lectin-bearing polymerized liposomes as potential oral vaccine carriers
187. Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
188. Studies on the uptake of tomato lectin nanoparticles in everted gut sacs
189. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat
190. Endogenous carreirs and ligands in nonimmunogenic site-specific drug delivery
191. Soluble N-(2-hydroxypropyl) methacrylamide copolymers as a potential oral controlled-release drug delivery system. I. Bioadhesion to the rat intestine in vitro
192. In vitro bioadhesion of carbohydrate-containing N-(2-hydrohypropyl) methacrylamide copolymers to the GI tract of guinea pigs
193. Identification of classes of proteins that provide an immune response upon oral feeding
194. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell directed lectins
195. Receptor-mediated gene delivery employing lectin-binding specificity
196. K88 adhesins of enterotoxigenic Escherichia coli and their porcine enterocyte receptors
197. The potential of fimbrial proteins for delaying intestinal transit of oral drug delivery systems
198. Yersinia enterocolitica invasin: A primary role in the initiation of infection
199. Discrimination between intracellular uptake and surface adhesion of bacterial pathogens
200. Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic proteins of Escherichia coli Citrobacter freundii, and Hafnia alvei
201. Utilising bacterial mechanisms of epithelial cell entry: Invasin-induced oral uptake of latex nanoparticles
202. Ruffles induced by Salmonella and other stimuli direct macropinocytosis of bacteria
203. Modulation of intestinal permeability: An innovative method of oral drug delivery for the treatment of inherited and acquired human diseases
204. Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens
205. Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant
206. Adjuvant effect of B-subunit of E. coli heat-labile toxin on secretory antibody response to oral influenza virus immunization in mice
207. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems
208. Oral immunization with influenza virus: Experimental and clinical studies
209. Mucosal immunogenicity of plant lectins in mice
210. Lectins and superantigens: Membrane interactions of these compounds with T lymphocytes affect immune responses
211. Lectins and the immune system
212. Modulatory potency of drum stick lectin in the host defense system
213. Enhancement of reagenic antibody formation in the mouse by concanavalin A
214. Modulation of IgE response by phytohemagglutinin
215. Effects of multiple oral dosing on IgE synthesis in mice-oral sensitization by albumin extracts from seeds of Jackfruit (Artocarpus integfolia) containing lectins
216. The potent IgG4-inducing antigen in banana is a mannose-binding lectin BanLec-1
217. The identification of plant lectins with mucosal adjuvant activity
218. The adjuvant effect of jacalin on the mouse humoral immune response to trinitrophenyl and Trypanosoma cruzi
219. Reovirus type 1 infection of small intestinal epithelium in suckling mice and its effect on M cells
220. Intestinal M cells: A pathway for entry of reovirus into the host
221. Immunotoxins against cancer
222. Recent advances in the uses and applications of ribosome-inactivating proteins from plants
223. Immunotoxins containing A-chain of mistletoe lectin I are more active than immunotoxins with ricin A-chain
224. Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes: Comparison of efficiency and specificity
225. Immunotoxins in cancer therapy
226. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
227. Oral immunization against Helicobacter pylor: A future concept
228. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids
229. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection
230. Oral immunization with the dodecapeptide repeat of the serinerich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response
231. B72 (CD86) but not B71 (CD80) costimulation is required for the induction of low dose oral tolerance
232. Intranasal administration of a Shistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice
233. 12-mediated uptake of erythropoietin and granulocyte colony stimulating factor in vitro and in vivo
234. Development of dome epithelium in gut-associated lymphoid tissues: Association of IgA with M cells
235. Binding and transepithelial transport of immunoglobulins by intestinal M cells: Demonstration using monoclonal IgA antibodies against enteric viral proteins
236. A study of secretory immunoglobulin A on membranous epithelial cells (M cells) and adjacent absorptive cells of rabbit Peyer's patches
237. Human intestinal epithelial cells express a novel receptor for IgA
238. Regulation of protein traffic in polarized epithelial cells
239. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: Possible role in transfer of immunoglobulin G from mother to fetus
240. Apical expression of functional asialoglycoprotein receptor in the human intestinal cell line HT-29
241. Confocal analysis of fluorescent bead uptake by mouse Peyer's patch follicle associated M cells
242. A pathogenspecific epitope inserted into recombinant secretory immunoglobulin A is immunogenic by the oral route
243. Enhanced toxicity of Bacillus thuringiensis Cry3A δ-endotoxin in coleopterans by mutagenesis in a receptor binding loop
244. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets
245. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains
246. Functional phytohemagglutinin (PHA) and Galanthus nivalis agglutinin (GNA) expressed in Pichia pastoris
247. Mechanisms of antigen handling by the gut
248. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop
249. In vitro study of lectin-latex conjugates for specific bioadhesion
250. Jacalin: An IgA-binding lectin
251. The C-type lectin superfamily in the immune system
252. The gut's role in metabolism mucosal barrier function and gut immunology
253. Mucin-like glycoproteins
254. Structure distribution and origin of M cells in Peyer's patches of mouse ileum
255. M-cells are damaged and increased in number in inflamed human ileal mucosa
256. Morphological study of microfold cells of intestinal lymphoid follicles in Peyer's patches
257. Postnatal changes in lectin binding to microvillus membranes from rat intestine
258. Dietary fat effects on brush border membrane composition and enzyme activities in rat intestine
259. Food poisoning from raw red kidney beans
260. Nutritional evaluation of kidney beans (Phaseolus vulgaris): The toxic principle
261. Binding of kidney bean (Phaseolus vulgaris) isolectins to differentiated human colon carcinoma Caco2 cells and their effect on cellular metabolism
262. Interaction of legume lectins with the cellular metabolism of differentiated Caco-2 cells
263. Dietary soya beans and kindey beans stimulate secretion of cholecystokininin and pancreatic digestive enzymes in 400-day-old Hooded-Lister rats but only soya beans induce growth of the pancreas
264. Biochemical studies on oral toxicity of ricin. IV. A fate of orally administered ricin in rats
265. Interaction of toxic lectin ricin with epithelial cells of rat small intestine
266. Revision of the nomenclature for the Bacillus thuringiensis pesticidal crystal proteins
267. Cry1Ac protoxin from Bacillus thuringiensis sp kurstaki HD73 binds to surface proteins in the mouse small intestine
268. Dietary lectins can induce in vitro release of IL-4 and IL-13 from human basophils
269. Mucin-related epitopes distinguish M cells and enterocytes in rabbit appendix and Peyer's patches
270. Human intestinal M cells display the sialyl Lewis A antigen
271. M-cell surface β1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells
272. Glycoconjugate expression in follicle-associated epithelium (FAE) covering the nasal-associated lymphoid tissue (NALT) in specific pathogenfree and conventional rats
273. Accessibility of glycolipid and oligosaccharide epitopes on rabbit villus and follicle-associated epithelium
274. Lectins for gastrointestinal targeting: 15 Years on
275. Lectin-mediated drug delivery: The second generation of bioadhesives
276. Endogenous lectins as targets for drug delivery